Skip to content

Clinical trials

Completed Phase 3 Hepatitis B, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Phase 3 Status: Completed Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20023
20034
20045
20057
20062
20073
20085
20103
20113
20122
20131
20151
20162
20171
20191
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb10
GlaxoSmithKline8
Gilead Sciences7
Hoffmann-La Roche6
Novartis4
Novartis Pharmaceuticals4
Merck Sharp & Dohme LLC2
Xiamen Amoytop Biotech Co., Ltd.2
Beijing Kawin Technology Share-Holding Co., Ltd.1
Dong-A ST Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic50
Hepatitis B14
Hepatitis3
Hepatitis, Chronic2
Bronchiolitis Obliterans Syndrome1
Chronic Disease1
Fibrosis1
HIV Infections1
HIV Seropositivity1
Hepatitis D1

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.